Preliminary Findings: The condition of recovering sufferers improves after receiving the vaccine

The U.S. Centers for Disease Control and Prevention (CDC) has declared that no safety risks are being recognized in a vaccine, and a series of studies have shown that one vaccine cream greatly improves the protection of recoverers from existing variants. Preliminary field reports indicate that recoverers who suffer from persistent symptoms even after their recovery, indicate a marked improvement in their condition after receiving a vaccine dose.

Kansas City, USA resident, Peniley, testified that she had symptoms that lasted for many months after she recovered from the corona virus. She saw that her oxygen status, among other things, was deteriorating dangerously, but gave up the emergency room because she did not have insurance. Various medications, but nothing helped or improved her condition.

After trying many and varied treatments, June’s condition in the American resident changed only after she received the first dose of the Corona virus. Suddenly her condition improved and she felt well. “A week after the vaccine, the symptoms disappeared and I felt better,” she says.

After recovering from the symptoms she experienced, a Kansas City resident decided to start a Facebook group in order to look for people like her who suffered even after recovering from the Corona virus. Over time, more and more testimonies began to accumulate in the group on the social network, by its participants, whose numbers suffered long after their recovery from fatigue, difficulty breathing and more, and after receiving a vaccine dose the condition improved and the severe symptoms disappeared. “This is something that needs to be researched in depth,” she concludes.

This is a phenomenon that researchers are noticing, although they claim it is too early to know whether corona virus vaccines, which are currently in use, may help or even cure the disease.

The vaccine is effective against the new mutations // Photo: Oren Ben Hakon
For the general population, vaccines are the most effective tool for reducing serious morbidity and preventing long-term damage (which has been observed in one in ten patients). Pfizer’s vaccine significantly reduces the risk of contracting the virus, starting a week after the second dose.

In Israel, the vaccination campaign is probably giving its signals. The number of verified is steadily declining and the number of patients in critical condition is slowly declining. However, the extent of the morbidity is still high and one should beware of complacency.

The rate of positive tests has been declining for about a month and has dropped below four percent on a weekly average; The coefficient of infection has fallen sharply in recent days. These signs indicate a reduction in the extent of infections. The number of patients in a severe condition is relatively high (about 650 on a weekly average), but continues to decline slowly.

Despite the positive developments, continued relief may lead to a re-increase in morbidity, especially in those who have not yet been vaccinated.

The vaccines are effective, especially for recovering patients, as they are at risk of re-infection from the South African strain found in Israel and possibly similar strains, such as the Brazilian strain. Therefore, it is recommended that recoverers get vaccinated as soon as possible.

Increasing the number of entrances from abroad has increased the opening for new and diverse variants that may endanger recoverers and people who have not yet been vaccinated. Quickly and carries a mutation that infects repeatedly recovering.

.Source